FindTrial
Sign In

Use of immunohistochemical markers in Non Small Cell Lung Carcinoma with histopathological correlation

TTF-1 and P40 immunohistochemical markers as a useful panel in diagnosis of Non Small Cell Lung Carcinoma (NSCLC) with histopathological correlation- A cross sectional study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/02/031057
Enrollment
50
Registered
2021-02-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C34- Malignant neoplasm of bronchus andlung

Interventions

Intervention1: Histopathology: There are various methods that are being used to diagnose various lung tumors but core lung biopsy has a major role in diagnosing lung tumors as it is safe, rapid and re

Sponsors

Rohilkhand Medical College Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All histopathologically diagnosed cases of lung carcinomas of any age group or sex received in our Pathology Department during study period.

Exclusion criteria

Exclusion criteria: 1)Inadequate lung biopsies. 2)Non-carcinomatous lesions.

Design outcomes

Primary

MeasureTime frame
TTF-1 and P40 immunohistochemical markers as a useful panel in diagnosis of Non Small Cell Lung Carcinoma.Timepoint: Nil—

Secondary

MeasureTime frame
Role of TTF-1 and P40 immunohistochemical markers in differentiating NSCLC. Timepoint: Nil—

Countries

India

Contacts

Public ContactMayank Agrawal

Rohilkhand Medical College & Hospital, Bareilly

anjanaarya.singh15@gmail.com9412125824

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026